title: The physiology, pharmacology and future of P2X7 as an analgesic drug target: hype or promise?
abstract: P2X7 is an ATP-gated non-selective cation channel expressed primarily on cells of hematopoietic origin, such as macrophages and microglia. Since the initial cloning of this channel, enormous progress has been made in the understanding of the physiology, pharmacology and therapeutic utility of P2X7. This article attempts to review the biology of P2X7 with a focus on the complex pharmacology of this channel. Finally, the authors discuss the role of P2X7 as an analgesic drug target and raise some of the challenges and issues that face the P2X7 research community.
authors.affiliation: Neuroscience, Johnson & Johnson Pharmaceutical Research & Development LLC., San Diego, CA 92121, USA. abhatta2@its.jnj.com
authors.forename: Anindya
authors.initials: A
authors.lastname: Bhattacharya
authors.forename: Robert A
authors.initials: RA
authors.lastname: Neff
authors.forename: Alan D
authors.initials: AD
authors.lastname: Wickenden
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism; D010146:Pain / Q000188:drug therapy / Q000378:metabolism*; D058486:Receptors, Purinergic P2X7 / Q000502:physiology*
chemical_list: D000700:Analgesics; D058486:Receptors, Purinergic P2X7